Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Elanco Animal Health Incorporated ELAN
$8.52
-$0.27 (-3.13%)
На 18:01, 12 мая 2023
+216.90%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
4342323600.00000000
-
week52high
24.93
-
week52low
8.67
-
Revenue
4418000000
-
P/E TTM
-59
-
Beta
0.92175000
-
EPS
-0.15000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:00
Описание компании
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Overweight | 18 авг 2022 г. |
| Piper Sandler | Neutral | Neutral | 17 авг 2022 г. |
| JP Morgan | Neutral | Overweight | 16 авг 2022 г. |
| Goldman Sachs | Sell | Buy | 21 июл 2022 г. |
| JP Morgan | Overweight | Overweight | 18 июл 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 12 сент 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 07 окт 2022 г. |
| JP Morgan | Neutral | Neutral | 17 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 ноя 2022 г. |
| Piper Sandler | Neutral | Neutral | 14 ноя 2022 г. |
| Goldman Sachs | Sell | Sell | 09 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 30 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| YOUNG TODD S. | D | 0 | 1562 | 01 февр 2023 г. |
| YOUNG TODD S. | A | 6562 | 1562 | 01 февр 2023 г. |
| Meer James M | D | 18916 | 402 | 03 янв 2023 г. |
| HOOVER R DAVID | A | 26820 | 873 | 30 дек 2022 г. |
| BILBREY JOHN P | A | 14487 | 723 | 30 дек 2022 г. |
| Kurzius Lawrence Erik | A | 15215 | 750 | 30 дек 2022 г. |
| Herendeen Paul | A | 35956 | 18649 | 30 ноя 2022 г. |
| Kochevar Deborah Turner | A | 40857 | 18649 | 30 ноя 2022 г. |
| Harrington Michael J | A | 54120 | 18649 | 30 ноя 2022 г. |
| GARCIA ART A | A | 42421 | 18649 | 30 ноя 2022 г. |
Новостная лента
Elanco Animal Health Incorporated (ELAN) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
09 мая 2023 г. в 09:10
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.36 per share a year ago.
Why Elanco Animal Health Incorporated (ELAN) is Poised to Beat Earnings Estimates Again
Zacks Investment Research
02 мая 2023 г. в 13:43
Elanco Animal Health Incorporated (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Strong Mid-Cap Insider Buys: Q1 2023
Seeking Alpha
13 апр 2023 г. в 15:39
Today, we provide you the first quarter update in our recurring series based on firms that have enjoyed unusual insider interest during the first quarter of the year. We stand behind our belief that insiders supply the market with high-quality investment information each time they decide to trade their own company's shares on the open market.
Elanco 2022 Earnings: Speculative Value With Signs Of Progress
Seeking Alpha
23 февр 2023 г. в 13:12
Elanco Animal Health, an Eli Lilly spin-off, is the second-largest pure-play in the industry. On February 21, Elanco reported another largely disappointing year of restructuring, reorganization and poor financial performance, but there are a few signs of progress and improvement.
Elanco Animal Health Inc. (ELAN) Q4 2022 Earnings Call Transcript
Seeking Alpha
21 февр 2023 г. в 12:30
Elanco Animal Health Inc. (NYSE:ELAN ) Q4 2022 Results Conference Call February 21, 2023 8:00 AM ET Company Participants Katy Grissom - Head of Investor Relations Jeff Simmons - President and Chief Executive Officer Todd Young - Chief Financial Officer Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Morgan Stanley Chris Schott - JPMorgan Umer Raffat - Evercore ISI Jon Block - Stifel Elliot Wilbur - Raymond James Balaji Prasad - Barclays Brandon Vazquez - William Blair Operator Good morning, and welcome to Elanco Animal Health's Fourth Quarter and Full Year 2022 Earnings Call. All participants are in a listen-only mode.